Disease and Biomarker Profiling of Chinese Lupus Nephritis

Conditions: Characterize the Molecular Profile of Lupus Nephritis(LN) Patients to Understand Themechanism(s)Contributing to Patient Responsiveness to Soc; Integrated Analysis of LN Patient Molecular Profiling and Clinical Annotations to Understand LNdisease Heterogeneity for Disease Endotype; Validate the Association of the Candidate Biomarker Panel Proposed in Table 3-1 With LN Diseasemonitoring Interventions: Other Sponsors: Nan Shen; Novartis Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials